Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D0DR
|
||||
Former ID |
DNC010802
|
||||
Drug Name |
1-(3-(4-fluorophenyl)propyl)-1H-imidazole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528335] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H13FN2
|
||||
Canonical SMILES |
C1=CC(=CC=C1CCCN2C=CN=C2)F
|
||||
InChI |
1S/C12H13FN2/c13-12-5-3-11(4-6-12)2-1-8-15-9-7-14-10-15/h3-7,9-10H,1-2,8H2
|
||||
InChIKey |
BEKCOALNZLRGJA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [528335] | |
Cytochrome P450 19 | Target Info | Inhibitor | [530867] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
WikiPathways | Metapathway biotransformation | ||||
Steroid Biosynthesis | |||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Tryptophan metabolism | |||||
Ovarian Infertility Genes | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compounds | |||||
References | |||||
Ref 528335 | Bioorg Med Chem Lett. 2006 Sep 15;16(18):4752-6. Epub 2006 Jul 25.Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)). | ||||
Ref 530867 | Bioorg Med Chem Lett. 2010 May 15;20(10):3050-64. Epub 2010 Apr 8.Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.